摘要 |
The invention provides means and methods to predict, in subjects affected by type II diabetes (T2D), the probability of developing complications which include, but are not limited to, micro/ macrovascular disorder, hypertension, neuropathy, atrial fibrillation, nephropathy and other major adverse cardiovascular events (MACE) that are associated with the disease, by detecting one or more genetic features. The genetic features that are useful in prediction include, but are not limited to, genes, single nucleotide polymorphisms (SNPs) and other genomic markers. The invention further involves characterizing individuals based on the probability of developing complications related to T2D, such as, micro/ macrovascular disorder, hypertension, neuropathy, atrial fibrillation, nephropathy or MACE, based on the identification of one or more aforementioned genetic features. Also described are combinations and kits for carrying out the above-described methods. |
申请人 |
PROGNOMIX INC.;HAMET, PAVEL;TREMBLAY, JOHANNE;SEDA, ONDREJ;MACMAHON, STEPHEN;CHALMERS, JOHN |
发明人 |
HAMET, PAVEL;TREMBLAY, JOHANNE;SEDA, ONDREJ;MACMAHON, STEPHEN;CHALMERS, JOHN |